An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry

Description

Translational studies in cancer research can be impeded by the lack of high-quality clinical data that can be correlated with research questions. This is particularly true in the case of rare diseases, such as bone and soft tissue tumors. It is therefore the purpose of this study to create a prospective EHR-based clinical registry for individuals with bone and soft-tissue tumors.

Conditions

Neoplasms, Connective and Soft Tissue, Bone Neoplasms

Study Overview

Study Details

Study overview

Translational studies in cancer research can be impeded by the lack of high-quality clinical data that can be correlated with research questions. This is particularly true in the case of rare diseases, such as bone and soft tissue tumors. It is therefore the purpose of this study to create a prospective EHR-based clinical registry for individuals with bone and soft-tissue tumors.

An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry

An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry

Condition
Neoplasms, Connective and Soft Tissue
Intervention / Treatment

-

Contacts and Locations

Columbus

Ohio State University, Columbus, Ohio, United States, 43210

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Must have a diagnosis or presumed diagnosis of bone or soft tissue tumor as defined by the WHO classification of tumors of soft tissue and bone (4th ed.)
  • * Patient, or his/her designated power of attorney, must be able to understand and approve of the consent to participate.
  • * Prisoners are excluded from participation in the Registry.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Ohio State University Comprehensive Cancer Center,

David A Liebner, MD, PRINCIPAL_INVESTIGATOR, Ohio State University

Study Record Dates

2024-12-31